These data confirmed GLRX3 as a secretory biomarker protein detectable in human blood that is upregulated in the plasma of patients with pancreatic cancer than in healthy individuals or in chronic pancreatitis. This evidence concerns the gene GLRX3 and pancreatic neoplasm.